Third evaluation within the FINOSE collaboration

TLV

12 May 2020 - Together with the corresponding authorities in Finland and Norway, TLV has produced a joint evaluation report for the gene therapy Zynteglo within the FINOSE collaboration. 

The report was the basis for TLV's assessment of Zynteglo.

FINOSE is a collaboration between the Swedish Medicines Agency Fimea (Finland), the Swedish National Medicines Agency, NoMA (Norway) and TLV (Sweden).

Read TLV News [Swedish]

Michael Wonder

Posted by:

Michael Wonder